Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Notch homolog 2 N-terminal-like protein C (NOTCH2NLC) is a human-specific paralog of the canonical Notch receptors, belonging to a gene family that includes NOTCH2NLA and NOTCH2NLB[1][2][5]. It functions primarily as a modulator of the Notch signaling pathway, enhancing Notch receptor activation (NOTCH2, NOTCH1, and NOTCH3) and delaying differentiation of neuronal progenitor cells[2][5]. NOTCH2NLC is expressed in the developing human neocortex, especially in stem cell populations like outer radial glia, and plays a crucial role in increasing the number of cortical stem cells and, consequently, overall cortical neuron number and brain size[1][2][5]. While not a drug target or classical receptor, alterations such as copy number variations or repeat expansions in NOTCH2NLC are associated with neurodevelopmental and neurodegenerative diseases, including neuronal intranuclear inclusion disease (NIID)[5]. NOTCH2NLC is not known to be targeted by any drugs, and it is not classified under classical therapeutic target families like receptors, enzymes, or transporters.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Notch homolog 2 N-terminal-like protein C (NOTCH2NLC).